ANZSNM ASM 2026 Abstracts
Internal Medicine Journal · 2026-07 · 56 (S3) · 4-48
DOI: 10.1111/imj.70529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 15.07.2026.
Abstract (Originalsprache)
. Introduction: 68Ga-prostate-speci fi c membrane antigen (PSMA) PET/CT is widely used for staging and assessment of prostate cancer. However, PSMA expression is not exclusive to prostatic tissue and may be seen in non-prostatic conditions, including in fl ammatory vascular disease. This case demonstrates how an incidental fi nding of large vessel vasculitis on PSMA PET/CT signi fi cantly in fl uenced patient management and outcome. Detail of the case: A 67-year-old male with newly diagnosed prostate cancer underwent 68Ga-PSMA PET/CT for primary staging. He presented with a PSA of 6.2, increased urinary frequency, and MRI fi ndings of a PIRADS 4 lesion in the left prostate lobe. The patient reported no constitutional symptoms, was physically active, and had no signi fi cant past medical history. The PET/CT was performed 48 min following administration of 176 MBq of 68Ga-PSMA, with whole-body acquisition from vertex to toes. Imaging demonstrated focal radiotracer uptake in the left prostate lobe consistent with the known malignancy. In addition, there was unexpected uptake within the walls of the thoracic and abdominal aorta without dense calci fi cation. The fi ndings raised suspicion for incidental vasculitis, prompting recommendations for in fl ammatory marker assessment and further imaging. Following prostatectomy, the patient returned three months later for 18F-FDG PET/CT. In fl ammatory markers were elevated, and the patient reported a 12-month history of leg and buttock muscle aches. FDG PET/CT demonstrated more extensive vascular involvement, including the carotid arteries, distal abdominal aorta, and common iliac vessels, as well as soft tissue uptake adjacent to spinous processes. These fi ndings were consistent with vasculitis and polymyalgia rheumatica.
Zitieren
APA
(2026). ANZSNM ASM 2026 Abstracts. Internal Medicine Journal, 56(S3), 4-48. https://doi.org/10.1111/imj.70529
Vancouver
ANZSNM ASM 2026 Abstracts. Internal Medicine Journal. 2026;56(S3):4-48. doi:10.1111/imj.70529
BibTeX
@article{euvimed2026,
title = {ANZSNM ASM 2026 Abstracts},
journal = {Internal Medicine Journal},
year = {2026},
volume = {56},
number = {S3},
pages = {4--48},
doi = {10.1111/imj.70529}
}
EUVIMED